Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at lapatinib, Herceptin (also called trastuzumab) and hormone therapy as the first treatment for breast cancer that has spread.
It is for women who have breast cancer that is both HER2 positive and .
Recruitment start: 1 December 2011
Recruitment end: 31 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Stephen Johnston
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 08 Mar 2017
CRUK internal database number: 9241
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
